NIH-funded research R01 grant

Fat-linked amino acids and fatty liver with heart disease risk

Official title: Lipidated Amino Acids in Cardiometabolic Diseases

Funded at Louisiana State Univ Hsc Shreveport · NIH-11324547 · Data updated 2026-11-12

This work looks at whether changes in fat-linked amino acids made in the liver are tied to fatty liver disease and a higher risk of clogged arteries.

More Cardiometabolic Diseases research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLouisiana State Univ Hsc Shreveport
NIH-funded
Lab location1 site (Shreveport, United States)
Project startJune 2, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$429,581
NIH project number5R01DK134011-05
Project IDNIH-11324547 on NIH RePORTER

Who could benefit from this research

Could help

Adults with NAFLD or NASH, especially those who also have signs of atherosclerosis or cardiovascular risk, would be the most relevant candidates.

Less likely to help

People without fatty liver disease or whose artery disease is unrelated to these metabolic pathways may not gain direct benefit from this research.

What this research studies

Researchers will compare liver tissue and blood samples from people with and without non-alcoholic fatty liver disease (NAFLD/NASH) to measure levels of N-acyl amino acids and related gene activity. They will use metabolomics and transcriptomics to find which enzymes and pathways that make or break these molecules are altered in disease. Lab models (including mice) will be used to test how changing these fat-linked amino acids affects liver inflammation and artery plaque formation. The goal is to find pathways that could be targeted to help both fatty liver and accelerated atherosclerosis.

Why it matters

Potential benefit: If successful, this work could reveal new drug targets or blood markers to treat or predict both fatty liver disease and related heart disease.

How similar studies have gone: Some prior studies have linked N-acyl amino acids to metabolism, but applying this knowledge to jointly target NASH and atherosclerosis is largely new.

Where this research is happening

  • Louisiana State Univ Hsc Shreveport
    Shreveport, United States
    Active

Researchers

  • Principal investigator: Rom, Oren — Louisiana State Univ Hsc Shreveport
  • Study coordinator: Rom, Oren

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.